Corient Capital Partners’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,279
| Closed | -$237K | – | 760 |
|
|
2022
Q1 | $237K | Buy |
+3,279
| New | +$237K | 0.02% | 629 |
|
|
2021
Q4 | – | Sell |
-6,057
| Closed | -$768K | – | 740 |
|
|
2021
Q3 | $768K | Buy |
6,057
+4,153
| +218% | +$527K | 0.06% | 264 |
|
|
2021
Q2 | $317K | Buy |
1,904
+18
| +1% | +$3K | 0.02% | 477 |
|
|
2021
Q1 | $343K | Buy |
1,886
+215
| +13% | +$39.1K | 0.03% | 411 |
|
|
2020
Q4 | $334K | Buy |
1,671
+261
| +19% | +$52.2K | 0.03% | 351 |
|
|
2020
Q3 | $309K | Sell |
1,410
-11
| -0.8% | -$2.41K | 0.04% | 338 |
|
|
2020
Q2 | $271K | Buy |
+1,421
| New | +$271K | 0.03% | 362 |
|